Watchdog calls on federal officials to advance the HHS deprescribing plan with strong patient protections, as psychiatry attempts to weaken antidepressant tapering reforms

Watchdog's decades-long advocacy for patient rights and safe psychotropic withdrawal gains powerful validation amid rising debate on psychiatric drug risks

New laws highlight Tennessee's proactive response to growing concerns over psychiatric drug risks and potential links to violence. CCHR says these reforms are needed nationwide

Group Calls for Ending Electroshock and Greater Disclosure of Psychiatric Drug Risks Linked to Violence

Protesters confront psychiatrists at APA meeting over forced treatment, electroshock therapy, and violence-linked drug risks.

Group Calls for Ending Electroshock and Greater Disclosure of Risks Associated with Psychiatric Drugs Triggering Violence

New federal actions emphasize informed consent, holistic care, and protection for children and adults from psychiatric drug risks—but broader access to deprescribing support remains essential

Fast-tracked psychedelics risk repeating psychiatric drug disasters as synthetic compounds are promoted as safe and natural, violating informed consent

Psychotropic drug-related violence cases with 720 deaths and 1,602 injuries fuel call for nationwide toxicology screening and database

Vulnerable elderly residents face serious risks and premature death from antipsychotics, as nursing homes and their prescribers evade meaningful accountability.

Mental health watchdog urges FDA to remove ECT devices from the market and Florida lawmakers to pass legislation prohibiting electroshock, following landmark international survey and UN guidance